Leslie Miller - Dec 18, 2023 Form 4 Insider Report for Better Therapeutics, Inc. (BTTX)

Role: Principal Accounting Officer
Signature: /s/ Leslie Miller
Stock symbol: BTTX
Transactions as of: Dec 18, 2023
Transactions value $: $0
Form type: 4
Date filed: 12/20/2023, 05:21 PM
Previous filing: Dec 7, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BTTX	Common Stock	Award	$0	+3.59K	+25%	$0.00	17.9K	Dec 18, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	The Reporting person was awarded 3,587 Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest on June 1, 2024.